According to Ajanta Pharma latest financial reports the total debt is $3.13M, an increase of 41.09% to 2022. At the end of 2022 company had $2.22M total debt. This figure represents the debts and financial obligations that Ajanta Pharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $3.13M | 41.09% |
2022 | $2.22M | -6.07% |
2021 | $2.36M | 55.55% |
2020 | $1.52M | 1825.76% |
2019 | $78.78K | - |